<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164751">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01818297</url>
  </required_header>
  <id_info>
    <org_study_id>1666</org_study_id>
    <secondary_id>G120146</secondary_id>
    <nct_id>NCT01818297</nct_id>
  </id_info>
  <brief_title>Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients</brief_title>
  <acronym>SubQStim</acronym>
  <official_title>SubQStim Pivotal Study: A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Subcutaneous Nerve Stimulation. Protocol 1666</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and efficacy of Subcutaneous Nerve
      Stimulation (SQS) (also known as Peripheral Nerve Stimulation [PNS]) in the reduction of
      chronic, intractable post-surgical back pain in adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a multi-center, prospective, randomized (1:1) parallel-group design.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Summarize adverse events for all subjects.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in average back pain with no increase in prescription pain medications</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare proportion of subjects with greater than or equal to 50% reduction in back pain intensity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction, Functional Disability, and Quality of Life, and worst back pain</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Changes in disability measured by Oswestry Disability Index (ODI); Compare subject satisfaction between groups; Changes in the quality of life measured by Short Form Health Survey (SF36); Changes in worst back pain intensity score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">323</enrollment>
  <condition>Failed Back Surgery Syndrome</condition>
  <condition>Post-laminectomy Syndrome</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment settings of Medtronic PrimeAdvanced® neurostimulator system implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control settings of Medtronic PrimeAdvanced® neurostimulator system implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PrimeAdvanced® neurostimulator system</intervention_name>
    <description>Neurostimulator and associated components</description>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Have persistent back pain for at least 6 months

          -  Had back surgery at least 6 months ago

          -  Have tried pain medications and physical therapy

          -  Read and understand written English or Spanish

          -  Male or non-pregnant female. If female of child-bearing potential, and if sexually
             active, must be using a medically-acceptable method of birth control during study
             participation

          -  Willing and able to undergo surgical implant procedure, attend visits as scheduled,
             and comply with the study requirements

          -  Have an expected lifespan greater than 12 months

        Key Exclusion Criteria:

          -  Have leg pain in addition to back pain.

          -  Currently enrolled in or plan to enroll in another drug and/or device study

          -  Have peripheral vascular disease, peripheral neuropathy, small-fiber neuropathy, or
             fibromyalgia

          -  Have an active systemic infection or are immunocompromised

          -  Will be exposed to diathermy or anticipate needing a full-body MRI scan

          -  Currently have an implantable cardiac pacemaker, defibrillator, or neurostimulator

          -  Treated with spinal cord stimulation, peripheral nerve stimulation, an intrathecal
             drug delivery system or requires additional back surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Mandybur, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayfield Clinic, University of Cincinnati</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SubQStim Clinical Reseach Study Team</last_name>
    <email>medtronicneurotrials@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Valley Pain Consultants</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Choi</last_name>
      <email>deborahc@valley.md</email>
    </contact>
    <investigator>
      <last_name>Daniel Choi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Carlsbad</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Merritt Island</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Compass Research, LLC</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert D. Terwilleger</last_name>
      <email>rterwilleger@compassresearch.com</email>
    </contact>
    <investigator>
      <last_name>Michael J Creamer, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Pascagoula</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Columbia Interventional Pain Center, LLP</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Joseph Meyer, MD, Ph.D</last_name>
      <email>djmeyerjr@columbiapaincenter.com</email>
    </contact>
    <investigator>
      <last_name>Donald Joseph Meyer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Cuyahoga Falls</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>DNA Advanced Pain Treatment Center</name>
      <address>
        <city>Greensburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandi Penatzer</last_name>
      <email>penatzerb@dnapain.com</email>
    </contact>
    <investigator>
      <last_name>Yeshvant Navalgund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenfield</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Failed Back Surgery Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
